A global leader in patient-focused medical innovations for structural heart disease and critical care monitoring, the company specializes in transcatheter heart valve replacement and repair systems. Its products are widely used in minimally invasive procedures, making it a key player in the medical device industry. Investors track its performance due to its strong market position and growth potential in cardiovascular treatments.
1 member of Congress has disclosed 2 trades in Edwards Lifesciences Corporation (EW), a Healthcare company. The buy/sell breakdown shows 2 purchases versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.